The Clinical Cancer Genetics Research Lab (CGRL) focuses on the discovery and functional characterization of inherited genetic variations that influence the risk of cancer. The lab has a track record in discovery of germ line mutations in cancer and novel loci using genome-wide association studies. The lab is currently utilizing large-scale next generation sequencing to understand the role of rare variants that are predicted to have physiological impact in human cancers. Recent publications include PMID: 27433846, PMID:26102509, PMID: 24013638,  PMID: 23349640, PMID:25569183, PMID: 22863192, PMID:27655433 and PMID:28873162. 

The lab is seeking a post-doctoral researcher and/or early career investigator to conduct identify novel candidate genes and variants that predispose to cancer susceptibility using next generation sequencing. An understanding of germline genetics and cancer biology and genetics is essential. The goal is to merge clinical and genotypic data to dissect complex phenotypes seen in cancers.

The successful applicant should have a PhD degree in cancer biology/genetics. We are specifically looking for individuals who have adequate exposure to both genetic algorithms and bioinformatics. The candidate is expected to work closely with the faculty, lab director, postdocs, technicians, and clinicians dissecting the mechanism of cancer susceptibility using large scale sequencing data available at MSKCC, as well as whole exome or genome data MSKCC provides an interactive setting with opportunities for collaboration with other independent research groups.

Appointment will be on an annual basis, with a starting salary as per NIH guidelines, based on qualification and prior experience. We hope to hire in the next 45 days. Generic applications are not encouraged.